What Researchers Did
The researchers looked back at a hyperbaric oxygen therapy (HBOT) registry to find which factors were linked to symptoms that remained after treatment in people with type I decompression sickness (DCS).
What They Found
In this retrospective study of 195 patients with type I decompression sickness, 131 patients (67.2%) still had symptoms after a single HBOT session, and a longer time from symptom onset to recompression was independently associated with residual symptoms (p = .004). Compared with patients treated within 24 hours, the adjusted odds ratios for residual symptoms were 2.24 for 24 to 96 hours (confidence interval 0.75 to 6.65), 3.31 for 96 to 240 hours (1.08 to 10.13), and 22.83 for more than 240 hours (2.45 to 231.43). Commercial and recreational divers had higher odds of residual symptoms than military divers (adjusted odds ratios 4.78 and 33.36).
What This Means for Canadian Patients
For people with type I decompression sickness, this study found that waiting longer before recompression was linked to a higher chance of symptoms remaining after a single HBOT session. Most patients in this group still had some symptoms at discharge. The abstract does not say whether these patients later had more treatment, so it cannot show what happens after the first session.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective registry analysis that shows associations only, and some of the confidence intervals are very wide (for example 2.45 to 231.43), so the size of the effect is uncertain.